JP2009526034A - Treatment of Duchenne muscular dystrophy - Google Patents

Por um escritor misterioso

Last updated 05 julho 2024

US20190177723A1 - Compositions and methods for treating duchenne muscular dystrophy and related disorders - Google Patents

WO2020261178A1 - Methods of treating duchenne muscular dystrophy using aav mini-dystrophin gene therapy - Google Patents

Duchenne UK and PPMD Announce 2022 Joint Call for Therapeutic Projects - Parent Project Muscular Dystrophy

US20190177723A1 - Compositions and methods for treating duchenne muscular dystrophy and related disorders - Google Patents

Sarepta's ELEVIDYS Leads the Way in the DMD Treatment Space

WO2020261178A1 - Methods of treating duchenne muscular dystrophy using aav mini-dystrophin gene therapy - Google Patents

Duchenne Muscular Dystrophy Treatment Market Size 2024-2032

WO2018170408A1 - Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat muscular dystrophy - Google Patents

WO2017062835A2 - Compositions and methods for treating duchenne muscular dystrophy and related disorders - Google Patents

US9506058B2 - Compositions for treating muscular dystrophy - Google Patents

WO2017062835A2 - Compositions and methods for treating duchenne muscular dystrophy and related disorders - Google Patents

Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up

Recomendado para você